Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.42 - $0.62 $30,618 - $45,198
-72,900 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$1.21 - $1.8 $27,830 - $41,400
-23,000 Reduced 23.98%
72,900 $120,000
Q2 2021

Aug 06, 2021

SELL
$1.56 - $1.98 $15,756 - $19,998
-10,100 Reduced 9.53%
95,900 $162,000
Q1 2021

May 14, 2021

BUY
$1.36 - $2.49 $17,272 - $31,623
12,700 Added 13.61%
106,000 $174,000
Q4 2020

Feb 12, 2021

BUY
$0.75 - $2.76 $54,450 - $200,375
72,600 Added 350.72%
93,300 $138,000
Q3 2020

Nov 13, 2020

BUY
$0.61 - $1.17 $4,270 - $8,189
7,000 Added 51.09%
20,700 $20,000
Q2 2020

Aug 13, 2020

SELL
$0.47 - $0.72 $8,742 - $13,392
-18,600 Reduced 57.59%
13,700 $9,000
Q1 2020

May 11, 2020

BUY
$0.36 - $0.74 $576 - $1,184
1,600 Added 5.21%
32,300 $14,000
Q4 2019

Feb 12, 2020

BUY
$0.35 - $0.58 $3,814 - $6,322
10,900 Added 55.05%
30,700 $16,000
Q3 2019

Nov 14, 2019

BUY
$0.38 - $0.52 $646 - $884
1,700 Added 9.39%
19,800 $9,000
Q2 2019

Aug 20, 2019

BUY
$0.39 - $0.7 $2,379 - $4,270
6,100 Added 50.83%
18,100 $7,000
Q1 2019

May 15, 2019

SELL
$0.43 - $0.68 $6,966 - $11,016
-16,200 Reduced 57.45%
12,000 $7,000
Q4 2018

Feb 14, 2019

BUY
$0.39 - $0.7 $10,998 - $19,740
28,200 New
28,200 $11,000
Q3 2018

Nov 14, 2018

SELL
$0.44 - $3.02 $37,752 - $259,116
-85,800 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.16 - $3.48 $42,984 - $69,252
19,900 Added 30.2%
85,800 $292,000
Q4 2017

Feb 14, 2018

BUY
$0.68 - $4.19 $44,812 - $276,121
65,900
65,900 $268,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Market Cap $2.26M
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.